Potential for immune-driven viral polymorphisms to compromise antiretroviral-based preexposure prophylaxis for prevention of HIV-1 infection
<h4>Objective</h4> <p>Long-acting rilpivirine is a candidate for pre-exposure prophylaxis (PrEP) for prevention of HIV-1 infection. However, rilpivirine resistance mutations at reverse transcriptase codon 138 (RT-E138X) occur naturally in a minority of HIV-1-infected persons; in p...
Main Authors: | Gatanaga, H, Brumme, Z, Adland, E, Reyes-Terán, G, Avila-Rios, S, Mejía-Villatoro, C, Hayashida, T, Chikata, T, Van Tran, G, Van Nguyen, K, Meza, R, Palou, E, Valenzuela-Ponce, H, Pascale, J, Porras-Cortés, G, Manzanero, M, Lee, G, Martin, J, Carrington, M, John, M, Mallal, S, Poon, A, Goulder, P, Takiguchi, M, Oka, S |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Lippincott, Williams & Wilkins
2017
|
Similar Items
-
Preexposure Prophylaxis and Patient Centeredness
by: Jonathan M. Snowden PhD, et al.
Published: (2016-09-01) -
The impact of HLA-Cw*12:02 on control of HIV-1 infection
by: Koyanagi M, et al.
Published: (2012-09-01) -
HIV antiretroviral preexposure prophylaxis
by: Richard Tjan
Published: (2015-12-01) -
AIDS vaccines and preexposure prophylaxis: is synergy possible?
by: Excler, J, et al.
Published: (2011) -
Effective suppression of HIV-1 replication by cytotoxic T lymphocytes specific for pol epitopes in conserved mosaic vaccine immunogens
by: Zou, C, et al.
Published: (2019)